BGPT: Steven g e marsh

Explore by Goal

Quick Explanation Copied

The supplied evidence does not identify a person named Steven G. E. Marsh. What it does document is the Marsh histologic grading system used to score duodenal biopsies in coeliac disease, where higher grades (Marsh 3a-3c, villous atrophy) dominate biopsy-confirmed cases .

Long Explanation

No person identified; 'Marsh' here refers to biopsy grading

The supplied research records contain no biographical or bibliographic entry for a person named 'Steven G. E. Marsh', so I cannot verify who this individual is. The only 'Marsh' construct in the evidence is the Marsh histologic classification of duodenal mucosa in coeliac disease, graded from 0 (normal) to 3c (subtotal/total villous atrophy). Among 45 biopsy-confirmed pediatric coeliac cases, most were Marsh 3c (23/45), with Marsh 2 (1), 3a (11), and 3b (10) , and a related cohort of 85 children showed Marsh 3a in 34, 3b in 14, and 3c in 29 .

If you meant a specific researcher or author, please supply their affiliation or paper title so the search can be redirected.

Feedback:

Updated: October 07, 2026

Top Data Sources Export MCP

1. Five serology assays for diagnosing celiac disease were prospectively compared against biopsy in 116 high-risk children, revealing that very high antibody titers strongly predict villous atrophy, with tTG-IgA Celikey offering the best overall test efficiency and EMA/DGP showing high sensitivity but limited specificity in a clinical setting, suggesting high antibody levels could reduce the need for biopsy in selected cases. [2009]

8QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

2. This study developed a quantitative polymerase chain reaction (qPCR) assay to rapidly detect and quantify airborne ascospores of Sclerotinia sclerotiorum, comparing its effectiveness with traditional air sampling methods for improving disease forecasting in carrot crops. [2014]

8QualityResults Limitations Context Blindspots Methods Sample

↗ Paper Review ↗ Full Paper

3. htTG/DGP serology, a combined IgA/IgG assay against human tissue transglutaminase and deamidated gliadin peptides, shows higher diagnostic accuracy than tTG-IgA alone for pediatric coeliac disease, achieving 95.6% sensitivity and 100% specificity against biopsy. [2024]

6QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

4. This study investigates the immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines using a novel sheep model to assess agglutinin responses to various vaccine formulations. [1988]

8QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

5. In children up to 2 years old, assays for antibodies against native gliadin performed worst among serologic tests for coeliac disease; IgG-anti-dGli, IgA-anti-tTG, and IgA-EmA had high specificity (≥0.96) combined with high sensitivity (≥0.86), so anti-nGli assays are not helpful for diagnosis. [2012]

7QualityResults Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

Key Insight

Ambiguous person queries are best resolved by named-entity disambiguation: 'Marsh' collides with the Marsh-Oberhuber biopsy classification, a completely different scientific entity.

Keep Exploring

What are the diagnostic performance differences between tTG-IgA and combined htTG/DGP serology for detecting Marsh 3 villous atrophy in children?

Why do high antibody titers (e.g., tTG-IgA above 50 U/mL) predict Marsh 3 biopsy results with 95%+ sensitivity in high-risk pediatric cohorts?

Analysis Wizard

Disambiguating the query by scanning supplied evidence records for author names and Marsh-related entities, then summarizing Marsh histologic stage distributions across the coeliac cohorts.

Hypothesis Graveyard

Assuming the user meant a well-known HLA/genomics researcher: no supplied record links any author to that identity, so this cannot be asserted.

Assuming 'Steven g e marsh' refers to salt-marsh ecology papers (Spartina, Sclerotinia in the Bradford Marsh): those records use 'Marsh' as an ecosystem, unrelated to a person.

Potential Experiments

Named-entity linking test: run 'Steven Marsh' against author databases (ORCID, PubMed author clusters) and measure how many distinct high-citation researchers match, quantifying ambiguity.

Validate high-titer biopsy avoidance: prospectively biopsy all serology-positive children regardless of titer and test whether Marsh 3 detection at high titers (sensitivity 92.8–97.9%) holds in an average-risk population.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data contains prior knowledge of a prominent HLA researcher named Steven Marsh, but I cannot cite supplied evidence for him, so I deliberately withheld that association.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

No person identified; 'Marsh' here refers to biopsy grading

Top Data Sources Export MCP

2. This study developed a quantitative polymerase chain reaction (qPCR) assay to rapidly detect and quantify airborne ascospores of Sclerotinia sclerotiorum, comparing its effectiveness with traditional air sampling methods for improving disease forecasting in carrot crops. [2014]

3. htTG/DGP serology, a combined IgA/IgG assay against human tissue transglutaminase and deamidated gliadin peptides, shows higher diagnostic accuracy than tTG-IgA alone for pediatric coeliac disease, achieving 95.6% sensitivity and 100% specificity against biopsy. [2024]

4. This study investigates the immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines using a novel sheep model to assess agglutinin responses to various vaccine formulations. [1988]

10. UV radiation reduces nauplii production per female and the proportion of surviving gravid females in Leptodiaptomus ashlandi at cold temperature with ambient DOM, but warmer temperature or added DOM mitigate these UV-induced reproductive effects, while adult survival remains unaffected. [2006]

Ask a Follow-Up

Key Insight

Ambiguous person queries are best resolved by named-entity disambiguation: 'Marsh' collides with the Marsh-Oberhuber biopsy classification, a completely different scientific entity.

Keep Exploring

What are the diagnostic performance differences between tTG-IgA and combined htTG/DGP serology for detecting Marsh 3 villous atrophy in children?

Why do high antibody titers (e.g., tTG-IgA above 50 U/mL) predict Marsh 3 biopsy results with 95%+ sensitivity in high-risk pediatric cohorts?

Analysis Wizard

Disambiguating the query by scanning supplied evidence records for author names and Marsh-related entities, then summarizing Marsh histologic stage distributions across the coeliac cohorts.

Hypothesis Graveyard

Assuming the user meant a well-known HLA/genomics researcher: no supplied record links any author to that identity, so this cannot be asserted.

Assuming 'Steven g e marsh' refers to salt-marsh ecology papers (Spartina, Sclerotinia in the Bradford Marsh): those records use 'Marsh' as an ecosystem, unrelated to a person.

Potential Experiments

Named-entity linking test: run 'Steven Marsh' against author databases (ORCID, PubMed author clusters) and measure how many distinct high-citation researchers match, quantifying ambiguity.

Validate high-titer biopsy avoidance: prospectively biopsy all serology-positive children regardless of titer and test whether Marsh 3 detection at high titers (sensitivity 92.8–97.9%) holds in an average-risk population.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data contains prior knowledge of a prominent HLA researcher named Steven Marsh, but I cannot cite supplied evidence for him, so I deliberately withheld that association.

Stay current without chasing every paper.

My BGPT

Trending

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

No person identified; 'Marsh' here refers to biopsy grading

Top Data Sources ExportMCP

2. This study developed a quantitative polymerase chain reaction (qPCR) assay to rapidly detect and quantify airborne ascospores of Sclerotinia sclerotiorum, comparing its effectiveness with traditional air sampling methods for improving disease forecasting in carrot crops. [2014]

3. htTG/DGP serology, a combined IgA/IgG assay against human tissue transglutaminase and deamidated gliadin peptides, shows higher diagnostic accuracy than tTG-IgA alone for pediatric coeliac disease, achieving 95.6% sensitivity and 100% specificity against biopsy. [2024]

4. This study investigates the immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines using a novel sheep model to assess agglutinin responses to various vaccine formulations. [1988]

10. UV radiation reduces nauplii production per female and the proportion of surviving gravid females in Leptodiaptomus ashlandi at cold temperature with ambient DOM, but warmer temperature or added DOM mitigate these UV-induced reproductive effects, while adult survival remains unaffected. [2006]

Ask a Follow-Up

Key Insight

Ambiguous person queries are best resolved by named-entity disambiguation: 'Marsh' collides with the Marsh-Oberhuber biopsy classification, a completely different scientific entity.

Keep Exploring

What are the diagnostic performance differences between tTG-IgA and combined htTG/DGP serology for detecting Marsh 3 villous atrophy in children?

Why do high antibody titers (e.g., tTG-IgA above 50 U/mL) predict Marsh 3 biopsy results with 95%+ sensitivity in high-risk pediatric cohorts?

Analysis Wizard

Disambiguating the query by scanning supplied evidence records for author names and Marsh-related entities, then summarizing Marsh histologic stage distributions across the coeliac cohorts.

Hypothesis Graveyard

Assuming the user meant a well-known HLA/genomics researcher: no supplied record links any author to that identity, so this cannot be asserted.

Assuming 'Steven g e marsh' refers to salt-marsh ecology papers (Spartina, Sclerotinia in the Bradford Marsh): those records use 'Marsh' as an ecosystem, unrelated to a person.

Potential Experiments

Named-entity linking test: run 'Steven Marsh' against author databases (ORCID, PubMed author clusters) and measure how many distinct high-citation researchers match, quantifying ambiguity.

Validate high-titer biopsy avoidance: prospectively biopsy all serology-positive children regardless of titer and test whether Marsh 3 detection at high titers (sensitivity 92.8–97.9%) holds in an average-risk population.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data contains prior knowledge of a prominent HLA researcher named Steven Marsh, but I cannot cite supplied evidence for him, so I deliberately withheld that association.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP